Prolonged ketamine therapy differentially rescues psychobehavioural deficits via modulation of nitro-oxidative stress and oxytocin receptors in the gut-brain-axis of chronically-stressed mice.
Psychoneuroendocrinology December 1, 2023 Edem Ekpenyong Edem, Oluwatomisn Adeyosola Oguntala, Daniel Akinwale Ikuelogbon et al. 4 citations
Ketamine is an anaesthetic known to have short but rapid-acting anti-depressant effects; however, the neurobehavioural effects of its prolonged use and its role on the oxytocin system in the gut-brain axis are largely undetermined. Female BALB/c mice were either exposed to the chronic unpredictable mild stress (CUMS) paradigm for 21 days and then treated with ketamine in four doses for 14 days...
DOI: 10.1016/j.psyneuen.2023.106370 (opens in new tab)
Full text (opens in new tab)
Ketamine
Depression-associated behaviours
Gut-brain axis
Oxidative/nitrergic stress
+1